The stock's market cap is $2.77 million. DXTR's current price-earnings ratio amounts above the average P/E ratio of 111.47 times earnings.
Dextera Surgical Inc. has a consensus outperform rating from 2 Wall Street analysts, and the number of shares now sold short amount to at least 38.74% of shares outstanding.
The company's 50-day moving average price is $0.27 and its 200-day moving average price is $0.76. Dextera Surgical has a one year low of $0.17 and a one year high of $2.65. Wedbush reduced their price target on Dextera Surgical from $3.50 to $0.70 and set an "outperform" rating on the stock in a report on Wednesday, July 12th.
At the moment 2 analysts are watching Dextera Surgical Inc.
Dextera Surgical (NASDAQ:DXTR) last issued its earnings results on Tuesday, August 8th. Company has far performed well this year, with the share price down -67.71% since January. The lowest price the stock reached in the last trading day was $31.7 and compares with the $14 52-week low.
Atlanta gym bans police officers, military from joining
The Atlanta Police Department told the station that the policy wouldn't prevent them from responding to an emergency at the gym. That being said Chambers has removed the sign.for now, although he intends to put it back up, without the curse word.
To stay one step ahead we extended our research by comparing different price targets. The lowest 12-month price target for the shares is $0.40, which would be an increase of about 29% of its current value. Dextera Surgical Inc. (NASDAQ:DXTR) notched a 12-month high of $0.55 while $0.70 target is by far the most aggressive out of analysts who are now evaluating DXTR, $0.15 higher than the next highest 52-week price estimate.
Taking a glance at where the stock might be directed in the future, on a consensus basis, the sell-side has a 52 week price target of $0.7 on the stock, this valuation is based on 2 number of opinions.
The company's consensus rating on Reuter's scale remained unchanged from 1.77 to 1.77 during a month. The target implies a 17.21% spike from where the shares are now trading. The company is expected to report EPS as high as $-0.49 and as low as $-0.49 per share. The mean EPS estimate is $-1.02. The volume of 5.1 Million shares climbed down over an trading activity of 6.48 Million shares. Similarly, full-year sales forecasts have ranged between $3.4 Million and $3.55 Million. News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. with MarketBeat.com's FREE daily email newsletter. The 1 year EPS growth rate is 16.80%.
What Guru's think About Is Dextera Surgical Inc. At present, 5 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data.
Comments